Exercise testing in severe emphysema: Association with quality of life and lung function

Cynthia Brown, Joshua O. Benditt, Frank C. Sciurba, Shing M. Lee, Gerard J. Criner, Zab Mosenifar, David M. Shade, William A. Slivka, Robert A. Wise

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Six-minute walk testing (6MWT) and cardiopulmonary exercise testing (CPX) are used to evaluate impairment in emphysema. However, the extent of impairment in these tests as well as the correlation of these tests with each other and lung function in advanced emphysema is not well characterized. During screening for the National Emphysema Treatment Trial, maximum ergometer CPX and 6MWT were performed in 1,218 individuals with severe COPD with an average FEV1 of 26.9 ± 7.1 % predicted. Predicted values for 6MWT and CPX were calculated from reference equations. Correlation coefficients and multivariable regression models were used to determine the association between lung function, quality of life (QOL) scores, and exercise measures. The two forms of exercise testing were correlated with each other (r = 0.57, p < 0.0001). However, the impairment of performance on CPX was greater than on the 6MWT (27.6 ± 16.8 vs. 67.9 ± 18.9 % predicted). Both exercise tests had similar correlation with measures of QOL, but maximum exercise capacity was better correlated with lung function measures than 6-minute walk distance. After adjustment, 6MWD had a slightly greater association with total SGRQ score than maximal exercise (effect size 0.37 ± 0.04 vs. 0.25 ± 0.03 %predicted/unit). Despite advanced emphysema, patients are able to maintain 6MWD to a greater degree than maximum exercise capacity. Moreover, the 6MWT may be a better test of functional capacity given its greater association with QOL measures whereas CPX is a better test of physiologic impairment.

Original languageEnglish (US)
Pages (from-to)117-124
Number of pages8
JournalCOPD: Journal of Chronic Obstructive Pulmonary Disease
Volume5
Issue number2
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Emphysema
Quality of Life
Exercise
Lung
Exercise Test
Chronic Obstructive Pulmonary Disease

Keywords

  • Clinical trial
  • Emphysema
  • Exercise tests
  • Lung diseases
  • Multicenter studies
  • Obstructive
  • Quality of life

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Exercise testing in severe emphysema : Association with quality of life and lung function. / Brown, Cynthia; Benditt, Joshua O.; Sciurba, Frank C.; Lee, Shing M.; Criner, Gerard J.; Mosenifar, Zab; Shade, David M.; Slivka, William A.; Wise, Robert A.

In: COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 5, No. 2, 04.2008, p. 117-124.

Research output: Contribution to journalArticle

Brown, C, Benditt, JO, Sciurba, FC, Lee, SM, Criner, GJ, Mosenifar, Z, Shade, DM, Slivka, WA & Wise, RA 2008, 'Exercise testing in severe emphysema: Association with quality of life and lung function', COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 5, no. 2, pp. 117-124. https://doi.org/10.1080/15412550801941265
Brown, Cynthia ; Benditt, Joshua O. ; Sciurba, Frank C. ; Lee, Shing M. ; Criner, Gerard J. ; Mosenifar, Zab ; Shade, David M. ; Slivka, William A. ; Wise, Robert A. / Exercise testing in severe emphysema : Association with quality of life and lung function. In: COPD: Journal of Chronic Obstructive Pulmonary Disease. 2008 ; Vol. 5, No. 2. pp. 117-124.
@article{f88d11a014c04d3b8fb89b2b9795c816,
title = "Exercise testing in severe emphysema: Association with quality of life and lung function",
abstract = "Six-minute walk testing (6MWT) and cardiopulmonary exercise testing (CPX) are used to evaluate impairment in emphysema. However, the extent of impairment in these tests as well as the correlation of these tests with each other and lung function in advanced emphysema is not well characterized. During screening for the National Emphysema Treatment Trial, maximum ergometer CPX and 6MWT were performed in 1,218 individuals with severe COPD with an average FEV1 of 26.9 ± 7.1 {\%} predicted. Predicted values for 6MWT and CPX were calculated from reference equations. Correlation coefficients and multivariable regression models were used to determine the association between lung function, quality of life (QOL) scores, and exercise measures. The two forms of exercise testing were correlated with each other (r = 0.57, p < 0.0001). However, the impairment of performance on CPX was greater than on the 6MWT (27.6 ± 16.8 vs. 67.9 ± 18.9 {\%} predicted). Both exercise tests had similar correlation with measures of QOL, but maximum exercise capacity was better correlated with lung function measures than 6-minute walk distance. After adjustment, 6MWD had a slightly greater association with total SGRQ score than maximal exercise (effect size 0.37 ± 0.04 vs. 0.25 ± 0.03 {\%}predicted/unit). Despite advanced emphysema, patients are able to maintain 6MWD to a greater degree than maximum exercise capacity. Moreover, the 6MWT may be a better test of functional capacity given its greater association with QOL measures whereas CPX is a better test of physiologic impairment.",
keywords = "Clinical trial, Emphysema, Exercise tests, Lung diseases, Multicenter studies, Obstructive, Quality of life",
author = "Cynthia Brown and Benditt, {Joshua O.} and Sciurba, {Frank C.} and Lee, {Shing M.} and Criner, {Gerard J.} and Zab Mosenifar and Shade, {David M.} and Slivka, {William A.} and Wise, {Robert A.}",
year = "2008",
month = "4",
doi = "10.1080/15412550801941265",
language = "English (US)",
volume = "5",
pages = "117--124",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Exercise testing in severe emphysema

T2 - Association with quality of life and lung function

AU - Brown, Cynthia

AU - Benditt, Joshua O.

AU - Sciurba, Frank C.

AU - Lee, Shing M.

AU - Criner, Gerard J.

AU - Mosenifar, Zab

AU - Shade, David M.

AU - Slivka, William A.

AU - Wise, Robert A.

PY - 2008/4

Y1 - 2008/4

N2 - Six-minute walk testing (6MWT) and cardiopulmonary exercise testing (CPX) are used to evaluate impairment in emphysema. However, the extent of impairment in these tests as well as the correlation of these tests with each other and lung function in advanced emphysema is not well characterized. During screening for the National Emphysema Treatment Trial, maximum ergometer CPX and 6MWT were performed in 1,218 individuals with severe COPD with an average FEV1 of 26.9 ± 7.1 % predicted. Predicted values for 6MWT and CPX were calculated from reference equations. Correlation coefficients and multivariable regression models were used to determine the association between lung function, quality of life (QOL) scores, and exercise measures. The two forms of exercise testing were correlated with each other (r = 0.57, p < 0.0001). However, the impairment of performance on CPX was greater than on the 6MWT (27.6 ± 16.8 vs. 67.9 ± 18.9 % predicted). Both exercise tests had similar correlation with measures of QOL, but maximum exercise capacity was better correlated with lung function measures than 6-minute walk distance. After adjustment, 6MWD had a slightly greater association with total SGRQ score than maximal exercise (effect size 0.37 ± 0.04 vs. 0.25 ± 0.03 %predicted/unit). Despite advanced emphysema, patients are able to maintain 6MWD to a greater degree than maximum exercise capacity. Moreover, the 6MWT may be a better test of functional capacity given its greater association with QOL measures whereas CPX is a better test of physiologic impairment.

AB - Six-minute walk testing (6MWT) and cardiopulmonary exercise testing (CPX) are used to evaluate impairment in emphysema. However, the extent of impairment in these tests as well as the correlation of these tests with each other and lung function in advanced emphysema is not well characterized. During screening for the National Emphysema Treatment Trial, maximum ergometer CPX and 6MWT were performed in 1,218 individuals with severe COPD with an average FEV1 of 26.9 ± 7.1 % predicted. Predicted values for 6MWT and CPX were calculated from reference equations. Correlation coefficients and multivariable regression models were used to determine the association between lung function, quality of life (QOL) scores, and exercise measures. The two forms of exercise testing were correlated with each other (r = 0.57, p < 0.0001). However, the impairment of performance on CPX was greater than on the 6MWT (27.6 ± 16.8 vs. 67.9 ± 18.9 % predicted). Both exercise tests had similar correlation with measures of QOL, but maximum exercise capacity was better correlated with lung function measures than 6-minute walk distance. After adjustment, 6MWD had a slightly greater association with total SGRQ score than maximal exercise (effect size 0.37 ± 0.04 vs. 0.25 ± 0.03 %predicted/unit). Despite advanced emphysema, patients are able to maintain 6MWD to a greater degree than maximum exercise capacity. Moreover, the 6MWT may be a better test of functional capacity given its greater association with QOL measures whereas CPX is a better test of physiologic impairment.

KW - Clinical trial

KW - Emphysema

KW - Exercise tests

KW - Lung diseases

KW - Multicenter studies

KW - Obstructive

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=42249090854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249090854&partnerID=8YFLogxK

U2 - 10.1080/15412550801941265

DO - 10.1080/15412550801941265

M3 - Article

C2 - 18415810

AN - SCOPUS:42249090854

VL - 5

SP - 117

EP - 124

JO - COPD: Journal of Chronic Obstructive Pulmonary Disease

JF - COPD: Journal of Chronic Obstructive Pulmonary Disease

SN - 1541-2555

IS - 2

ER -